Expanding the Reach of Personalized Medicine in Cancer Care: Current Progress and Future Directions of JCO Precision Oncology

JCO Precis Oncol. 2024 May:8:e2400068. doi: 10.1200/PO.24.00068.

Authors

Yushu Shi¹, J Bryan Iorgulescu², Stephanie Valladao³, Danielle F Atibalentja⁴

Affiliations

¹ Department of Population Health Sciences, Division of Biostatistics, Weill Cornell Medicine, New York City, NY.
² Molecular Diagnostics Laboratory, Department of Hematopathology, Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.
³ American Society of Clinical Oncology, Alexandria, VA.
⁴ Department of Medicine, Division of Oncology, Stanford University, School of Medicine, Palo Alto, CA.

PMID: 38815181
DOI: 10.1200/PO.24.00068

Abstract

ASCO Editorial Fellows share insights into publication trends and future directions for JCO Precision Oncology.

Publication types

Editorial

MeSH terms

Humans
Medical Oncology* / methods
Medical Oncology* / trends
Neoplasms* / genetics
Neoplasms* / therapy
Periodicals as Topic
Precision Medicine*